WO2005037246A3 - Wässrige aerosol-zubereitung - Google Patents
Wässrige aerosol-zubereitung Download PDFInfo
- Publication number
- WO2005037246A3 WO2005037246A3 PCT/EP2004/011571 EP2004011571W WO2005037246A3 WO 2005037246 A3 WO2005037246 A3 WO 2005037246A3 EP 2004011571 W EP2004011571 W EP 2004011571W WO 2005037246 A3 WO2005037246 A3 WO 2005037246A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparations
- administering
- aqueous aerosol
- active substances
- aerosol preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004281531A AU2004281531A1 (en) | 2003-10-15 | 2004-10-14 | Aqueous aerosol preparation |
BRPI0415470-3A BRPI0415470A (pt) | 2003-10-15 | 2004-10-14 | preparação em aerossol aquosa |
MXPA06004132A MXPA06004132A (es) | 2003-10-15 | 2004-10-14 | Preparacion acuosa en aerosol. |
EP04790427A EP1673066A2 (de) | 2003-10-15 | 2004-10-14 | Wässrige aerosol-zubereitung |
NZ546824A NZ546824A (en) | 2003-10-15 | 2004-10-14 | Aqueous aerosol preparation |
CA002542666A CA2542666A1 (en) | 2003-10-15 | 2004-10-14 | Aqueous aerosol preparation |
US11/106,999 US7758886B2 (en) | 2003-10-15 | 2005-04-14 | Pharmaceutical aerosol composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10347994A DE10347994A1 (de) | 2003-10-15 | 2003-10-15 | Wässrige Aerosol-Zubereitung |
DE10347994.5 | 2003-10-15 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/106,999 Continuation-In-Part US7758886B2 (en) | 2003-10-15 | 2005-04-14 | Pharmaceutical aerosol composition |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005037246A2 WO2005037246A2 (de) | 2005-04-28 |
WO2005037246A3 true WO2005037246A3 (de) | 2005-12-08 |
Family
ID=34441978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/011571 WO2005037246A2 (de) | 2003-10-15 | 2004-10-14 | Wässrige aerosol-zubereitung |
Country Status (10)
Country | Link |
---|---|
US (1) | US7758886B2 (de) |
EP (1) | EP1673066A2 (de) |
AU (1) | AU2004281531A1 (de) |
BR (1) | BRPI0415470A (de) |
CA (1) | CA2542666A1 (de) |
DE (1) | DE10347994A1 (de) |
MX (1) | MXPA06004132A (de) |
NZ (1) | NZ546824A (de) |
RU (1) | RU2363449C2 (de) |
WO (1) | WO2005037246A2 (de) |
Families Citing this family (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
US20030199425A1 (en) * | 1997-06-27 | 2003-10-23 | Desai Neil P. | Compositions and methods for treatment of hyperplasia |
TW465235B (en) | 1998-09-17 | 2001-11-21 | United Video Properties Inc | Electronic program guide with digital storage |
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
CA2733850C (en) | 2000-04-11 | 2013-10-22 | Trudell Medical International | Aerosol delivery apparatus with positive expiratory pressure capacity |
US20030205226A1 (en) | 2002-05-02 | 2003-11-06 | Pre Holding, Inc. | Aerosol medication inhalation system |
US6904908B2 (en) | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
US8545463B2 (en) | 2003-05-20 | 2013-10-01 | Optimyst Systems Inc. | Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device |
US7883031B2 (en) | 2003-05-20 | 2011-02-08 | James F. Collins, Jr. | Ophthalmic drug delivery system |
US20050026948A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a betamimetic |
DE10347994A1 (de) | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
PE20050941A1 (es) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US7878978B2 (en) | 2004-03-18 | 2011-02-01 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Use of relaxin to increase arterial compliance |
ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
GB2419094A (en) * | 2004-10-12 | 2006-04-19 | Sandoz Ag | Pharmaceutical composition of unpleasnt tasing active substances |
GB0501956D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Internat | Nebulizer formulation |
US20090220587A1 (en) * | 2005-02-01 | 2009-09-03 | United State Army | Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
US7741431B2 (en) * | 2005-02-01 | 2010-06-22 | The United States Of America As Represented By The Secretary Of The Army | Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof |
GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
EP1712220A1 (de) * | 2005-04-15 | 2006-10-18 | PARI GmbH Spezialisten für effektive Inhalation | Pharmazeutische Aerosolzusammensetzung |
GB0510463D0 (en) * | 2005-05-23 | 2005-06-29 | Britania Pharmaceuticals Ltd | Improvements in or relating to organic materials |
BRPI0613034A8 (pt) | 2005-07-14 | 2018-01-02 | Lipothera Inc | formulação injetável para acúmulo de tecido adiposo, formulação injetável e método para o tratamento de acúmulo de gordura, e, método para reduzir o tecido adiposo. |
EP1928410A2 (de) | 2005-09-29 | 2008-06-11 | Nektar Therapeutics | Antibiotische formulierungen, einheitsdosen, kits und verfahren |
US20070293460A1 (en) * | 2005-10-31 | 2007-12-20 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
DE102006051512A1 (de) * | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
PL1962805T3 (pl) | 2005-12-08 | 2017-01-31 | Insmed Incorporated | Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych |
US20070178050A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an increased lung depositon |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070178051A1 (en) * | 2006-01-27 | 2007-08-02 | Elan Pharma International, Ltd. | Sterilized nanoparticulate glucocorticosteroid formulations |
US20070202051A1 (en) * | 2006-02-10 | 2007-08-30 | Pari Gmbh | Aerosols for sinunasal drug delivery |
EP1820493A3 (de) * | 2006-02-10 | 2008-05-07 | PARI Pharma GmbH | Aerosole für die Arzneistoffabgabe in den Nasennebenhöhlen |
JP2009526860A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | 安定したコルチコステロイド混合物 |
GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
US7976873B2 (en) | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
US7959943B2 (en) | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
US20070264296A1 (en) | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
AU2007249736A1 (en) * | 2006-05-15 | 2007-11-22 | Wisconsin Alumni Research Foundation | Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin |
PL2077830T3 (pl) * | 2006-10-17 | 2013-04-30 | Lithera Inc | Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej |
US8088095B2 (en) | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
KR100868295B1 (ko) | 2007-02-15 | 2008-11-11 | 풍림무약주식회사 | 레플루노미드를 함유하는 고체분산체 및 이의 제조방법 |
DK2481409T3 (en) | 2007-03-07 | 2018-08-06 | Abraxis Bioscience Llc | Nanoparticle comprising rapamycin and albumin as anticancer agent |
WO2008131170A1 (en) * | 2007-04-18 | 2008-10-30 | Particle Sciences, Inc, | Aerosol dispersions of particles with active pharmaceutical ingredients |
EP3326630A3 (de) * | 2007-05-03 | 2018-08-29 | Abraxis BioScience, LLC | Verfahren und zusammensetzungen zur behandlung pulmonaler hypertonie |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
TW200904485A (en) * | 2007-05-18 | 2009-02-01 | Alcon Res Ltd | Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions |
US8927019B2 (en) | 2007-06-01 | 2015-01-06 | Abraxis Bioscience, Llc | Methods and compositions for treating recurrent cancer |
US20090053149A1 (en) * | 2007-08-24 | 2009-02-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Surfactant-based antimicrobial solution for inhalation |
EP2030644A1 (de) | 2007-08-31 | 2009-03-04 | PARI Pharma GmbH | Nasensprays zur sinunasalen Arzneimittelfreisetzung |
CA2698683A1 (en) * | 2007-09-07 | 2009-03-12 | Epigenesis Pharmaceuticals, Llc | Dheas inhalation compositions |
CA2701723A1 (en) * | 2007-10-25 | 2009-04-30 | Merck Frosst Canada Ltd. | Novel crystalline salts of montelukast |
WO2009086470A2 (en) * | 2007-12-27 | 2009-07-09 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
EP2242526A4 (de) * | 2008-02-15 | 2014-06-18 | Timothy Sean Immel | Aerosol-therapievorrichtung mit hochfrequenz-abgabe |
EP2100598A1 (de) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung |
EP2100599A1 (de) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung |
WO2009137611A2 (en) * | 2008-05-06 | 2009-11-12 | Board Of Regents, The University Of Texas System | Treatment of pulmonary fungal infection with voriconazole via inhalation |
CA2727432C (en) | 2008-06-12 | 2016-10-11 | Medtronic Xomed, Inc. | Method for treating chronic wounds with an extracellular polymeric substance solvating system |
WO2009156706A1 (en) * | 2008-06-27 | 2009-12-30 | University Of Strathclyde | Pulmonary drug delivery with vesicles comprising non-ionic surfactants |
TW201010727A (en) * | 2008-09-03 | 2010-03-16 | Alcon Res Ltd | Pharmaceutical composition having relatively low ionic strength |
US8551454B2 (en) * | 2009-03-13 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
US9132084B2 (en) | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
AU2011205646B2 (en) * | 2010-01-15 | 2014-10-02 | Neothetics, Inc. | Lyophilized cake formulations |
US20110208153A1 (en) * | 2010-02-24 | 2011-08-25 | John Alvey | Formulations and methods for nutrient delivery |
ES2391721T3 (es) * | 2010-03-01 | 2012-11-29 | Laboratorios Salvat, S.A. | Disoluciones acuosas transparentes de acetónido de fluocinolona para el tratamiento de la infamación de oído |
EA201390121A8 (ru) | 2010-07-15 | 2014-02-28 | Коринтиан Офтэлмик, Инк. | Способ и система для выполнения дистанционного лечения и контроля |
AU2011278924B2 (en) | 2010-07-15 | 2015-06-18 | Eyenovia, Inc. | Ophthalmic drug delivery |
US10154923B2 (en) | 2010-07-15 | 2018-12-18 | Eyenovia, Inc. | Drop generating device |
KR101545413B1 (ko) | 2010-07-15 | 2015-08-18 | 아이노비아 인코포레이티드 | 점적 발생 디바이스 |
CA2815374A1 (en) | 2010-11-24 | 2012-06-07 | Lithera, Inc. | Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging |
FR2971713B1 (fr) * | 2011-02-18 | 2019-03-29 | Laboratoire De La Mer | Solution ionique aqueuse contenant de l'eau de mer et au moins un compose originellement non miscible a l'eau de mer. |
US20120237550A1 (en) * | 2011-03-16 | 2012-09-20 | Siemens Healthcare Diagnostics Inc. | Maintaining Antibody-Binding Activity Of Immunosuppressant Drug Conjugates |
EP2510928A1 (de) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten |
CN102872017B (zh) * | 2011-07-13 | 2015-02-04 | 中国科学院上海药物研究所 | 6-(4-(二氟甲氧基)-3-甲氧基苯基)哒嗪-3(2h)-酮在制备抗肿瘤药物中的用途 |
WO2013090459A1 (en) | 2011-12-12 | 2013-06-20 | Corinthian Ophthalmic, Inc. | Ejector mechanism, ejector device, and methods of use |
JP6402097B2 (ja) | 2012-05-21 | 2018-10-10 | インスメッド インコーポレイテッド | 肺感染症を処置するためのシステム |
ES2743039T3 (es) | 2012-11-29 | 2020-02-18 | Insmed Inc | Formulaciones de vancomicina estabilizada |
US10172789B2 (en) | 2013-01-24 | 2019-01-08 | Palvella Therapeutics Llc | Compositions for transdermal delivery of mTOR inhibitors |
US20160317542A1 (en) | 2013-12-09 | 2016-11-03 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
EP2886121A1 (de) * | 2013-12-23 | 2015-06-24 | Dr. Falk Pharma Gmbh | Wässrige Suspension enthaltend Budesonid zur Behandlung von entzündlichen Veränderungen des Ösophagus |
US20150224078A1 (en) | 2014-02-10 | 2015-08-13 | Patara Pharma, LLC | Methods for the Treatment of Lung Diseases with Mast Cell Stabilizers |
SI3104853T1 (sl) * | 2014-02-10 | 2020-03-31 | Respivant Sciences Gmbh | Zdravljenje s stabilizatorji mastocitov za sistemske motnje |
US10286163B1 (en) * | 2014-03-04 | 2019-05-14 | Philip J. Paustian | On demand aerosolized delivery inhaler |
US10238675B2 (en) | 2014-05-15 | 2019-03-26 | Insmed Incorporated | Methods for treating pulmonary non-tuberculous mycobacterial infections |
KR101669556B1 (ko) * | 2014-07-02 | 2016-10-28 | 한미약품 주식회사 | 몬테루카스트 또는 이의 약제학적으로 허용가능한 염의 경구투여용 액상제제 |
JP2017529313A (ja) * | 2014-08-08 | 2017-10-05 | シンセン ハイタイド バイオファーマシューティカル リミテッド | 液体製剤組成物、薬物送達デバイス、ならびにそれらの調製および使用の方法 |
CN106137981B (zh) * | 2015-04-15 | 2019-10-15 | 中国医学科学院医药生物技术研究所 | 一种达比加群酯冻干纳米混悬剂及其制备方法 |
US10238625B2 (en) | 2015-08-07 | 2019-03-26 | Respivant Sciences Gmbh | Methods for the treatment of mast cell related disorders with mast cell stabilizers |
WO2017027402A1 (en) | 2015-08-07 | 2017-02-16 | Patara Pharma, LLC | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
MX2018014121A (es) | 2016-05-19 | 2019-04-29 | Trudell Medical Int | Camara de retencion con valvula inteligente. |
US10786638B2 (en) | 2016-07-08 | 2020-09-29 | Trudell Medical International | Nebulizer apparatus and method |
CA3028604C (en) | 2016-07-08 | 2023-12-05 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
CA3035528A1 (en) | 2016-08-31 | 2018-03-08 | Respivant Sciences Gmbh | Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis |
EP3522983A4 (de) | 2016-10-07 | 2020-06-03 | Respivant Sciences GmbH | Cromolynzusammensetzung zur behandlung von lungenfibrose |
CA3036631A1 (en) | 2016-12-09 | 2018-06-14 | Trudell Medical International | Smart nebulizer |
EP3565520A4 (de) | 2017-01-06 | 2020-08-19 | Palvella Therapeutics, Inc. | Wasserfreie zusammensetzungen von mtor-hemmern und verfahren zur verwendung |
JP7227163B2 (ja) | 2017-06-10 | 2023-02-21 | アイノビア,インコーポレイティド | 流体を取扱い、目に流体を送出するための方法および装置 |
RU2684563C2 (ru) * | 2017-08-14 | 2019-04-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ терапевтического лечения медикаментозного ринита, сформировавшегося на фоне приема назальных деконгестантов |
US11666801B2 (en) | 2018-01-04 | 2023-06-06 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
WO2019173884A1 (pt) * | 2018-03-15 | 2019-09-19 | Bebeachibuli Romeo | Normalizador biológico, processo de obtenção de normalizador biológico e produtos obtidos com o normalizador biológico |
WO2019191627A1 (en) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
CN108619118A (zh) * | 2018-04-16 | 2018-10-09 | 郭丽颖 | 一种肺部吸入用布地奈德自组装胶束 |
JP2021524505A (ja) * | 2018-05-19 | 2021-09-13 | ゲイリー ビンヤミン, | 発泡体製剤および身体への送達法 |
US11000513B2 (en) | 2018-07-02 | 2021-05-11 | Palvella Therapeutics, Inc. | Anhydrous compositions of mTOR inhibitors and methods of use |
EA202092892A1 (ru) * | 2018-12-04 | 2021-05-27 | Брес Терапьютикс Гмбх | Ингаляционные композиции, содержащие макроциклические иммуносупрессанты |
CA3152072A1 (en) | 2019-08-27 | 2021-03-04 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
RU2730938C1 (ru) * | 2019-11-05 | 2020-08-26 | Василий Михайлович Ахунов | Способ профилактики бронхиальной астмы при инфекции грибом рода Peacilomyces |
CN113018443B (zh) * | 2019-12-27 | 2022-09-13 | 海南斯达制药有限公司 | 治疗呼吸系统疾病的药物组合物及其制备方法 |
BR112022019519A2 (pt) | 2020-04-01 | 2022-11-16 | Union Therapeutics As | Tratamento |
AU2021247378A1 (en) | 2020-04-01 | 2022-11-10 | UNION therapeutics A/S | Formulation |
US11045434B1 (en) | 2020-04-01 | 2021-06-29 | UNION therapeutics A/S | Niclosamide formulations for treating disease |
US20230355898A1 (en) * | 2020-09-22 | 2023-11-09 | Micronization Technologies And Therapeutics Group Llc | Nebulizer and nebulized anti-virals |
RU2742505C1 (ru) * | 2020-10-01 | 2021-02-08 | Общество с ограниченной ответственностью "Институт термологии" | Аэрозоль для инвазивной механической вентиляции легких при covid-19 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
US5470583A (en) * | 1992-12-11 | 1995-11-28 | Eastman Kodak Company | Method of preparing nanoparticle compositions containing charged phospholipids to reduce aggregation |
WO1996013254A1 (en) * | 1994-10-26 | 1996-05-09 | Glaxo Wellcome House | Pharmaceutical composition comprising atovaquone |
WO1997029738A1 (en) * | 1996-02-16 | 1997-08-21 | The Administrators Of The Tulane Educational Fund | Methods and compositions for treating eustachian tube dysfunction by inhalation |
WO1997042938A1 (en) * | 1996-05-14 | 1997-11-20 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU76682A1 (de) | 1977-02-01 | 1977-06-27 | ||
US4150071A (en) | 1977-08-26 | 1979-04-17 | Respiratory Care, Inc. | Nebulizer |
US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
DE4203306A1 (de) | 1992-02-06 | 1993-08-12 | Ig Spruehtechnik Gmbh | Asthma oder pulmonal-aerosolzubereitungen mit lecithin |
DE4322111C2 (de) | 1993-07-02 | 2001-05-10 | Pari Gmbh | Inhalationsvernebler |
GB9410222D0 (en) | 1994-05-21 | 1994-07-06 | Glaxo Wellcome Australia Ltd | Medicaments |
IT1277832B1 (it) | 1995-03-02 | 1997-11-12 | Giuseppina Magni | Confezione per sostanze nebulizzabili |
US5660858A (en) | 1996-04-03 | 1997-08-26 | Research Triangle Pharmaceuticals | Cyclosporin emulsions |
US6465016B2 (en) | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US6086376A (en) | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
WO2000027376A2 (de) | 1998-10-26 | 2000-05-18 | Michael Schedler | Verwendung von thiolverbindungen, oxidoreduktasen und/oder hydrolasen zur behandlung des tinnitus, insbesondere des chronischen tinnitus |
RU2180217C2 (ru) | 2000-03-21 | 2002-03-10 | Закрытое акционерное общество "Пульмомед" | Стабильный водный раствор противовоспалительного действия, содержащий будесонид |
GB0009591D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical combinations |
GB0009605D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medicaments |
GB0009612D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic formulations |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US20020137764A1 (en) * | 2000-10-31 | 2002-09-26 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
DE10145361A1 (de) | 2001-09-14 | 2003-04-03 | Pari Gmbh | Verfahren zur Herstellung von flüssigen, sterilen Zubereitungen zur Inhalation |
EP1438019A1 (de) | 2001-10-24 | 2004-07-21 | PARI GmbH Spezialisten für effektive Inhalation | Set für die herstellung einer pharmazeutischen zusammensetzung |
US20030129242A1 (en) | 2002-01-04 | 2003-07-10 | Bosch H. William | Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
DE10239321B3 (de) | 2002-08-27 | 2004-04-08 | Pari GmbH Spezialisten für effektive Inhalation | Aerosoltherapievorrichtung |
EP2319584A1 (de) | 2002-08-29 | 2011-05-11 | Cipla Ltd. | Pharmazeutische Produkte und Zusammensetzungen enthaltend Salmeterol, Ciclesonid und Tiotropium |
DE10347994A1 (de) | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
-
2003
- 2003-10-15 DE DE10347994A patent/DE10347994A1/de not_active Withdrawn
-
2004
- 2004-10-14 AU AU2004281531A patent/AU2004281531A1/en not_active Abandoned
- 2004-10-14 WO PCT/EP2004/011571 patent/WO2005037246A2/de active Application Filing
- 2004-10-14 CA CA002542666A patent/CA2542666A1/en not_active Abandoned
- 2004-10-14 MX MXPA06004132A patent/MXPA06004132A/es unknown
- 2004-10-14 NZ NZ546824A patent/NZ546824A/en unknown
- 2004-10-14 BR BRPI0415470-3A patent/BRPI0415470A/pt not_active IP Right Cessation
- 2004-10-14 EP EP04790427A patent/EP1673066A2/de not_active Withdrawn
- 2004-10-14 RU RU2006114451/15A patent/RU2363449C2/ru not_active IP Right Cessation
-
2005
- 2005-04-14 US US11/106,999 patent/US7758886B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
US5470583A (en) * | 1992-12-11 | 1995-11-28 | Eastman Kodak Company | Method of preparing nanoparticle compositions containing charged phospholipids to reduce aggregation |
WO1996013254A1 (en) * | 1994-10-26 | 1996-05-09 | Glaxo Wellcome House | Pharmaceutical composition comprising atovaquone |
WO1997029738A1 (en) * | 1996-02-16 | 1997-08-21 | The Administrators Of The Tulane Educational Fund | Methods and compositions for treating eustachian tube dysfunction by inhalation |
WO1997042938A1 (en) * | 1996-05-14 | 1997-11-20 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
Also Published As
Publication number | Publication date |
---|---|
CA2542666A1 (en) | 2005-04-28 |
AU2004281531A1 (en) | 2005-04-28 |
NZ546824A (en) | 2010-01-29 |
WO2005037246A2 (de) | 2005-04-28 |
RU2363449C2 (ru) | 2009-08-10 |
US20050244339A1 (en) | 2005-11-03 |
DE10347994A1 (de) | 2005-06-16 |
RU2006114451A (ru) | 2007-11-20 |
BRPI0415470A (pt) | 2006-12-19 |
EP1673066A2 (de) | 2006-06-28 |
MXPA06004132A (es) | 2006-06-27 |
US7758886B2 (en) | 2010-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005037246A3 (de) | Wässrige aerosol-zubereitung | |
WO2007067520A3 (en) | Lipid-based compositions of antiinfectives for treating pulmonary infections | |
WO2006082588A3 (en) | Method and device for ophthalmic administration of active pharmaceutical ingredients | |
WO2006108556A3 (en) | Pharmaceutical aerosol composition | |
WO2007047948A3 (en) | Intranasal administration of rapid acting insulin | |
HK1088217A1 (en) | Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation | |
WO2002028422A3 (en) | Split enveloped virus preparation for intranasal delivery | |
CY1109223T1 (el) | Υγρα σκευασματα toy g-csf | |
MY142354A (en) | Acidic insulin preparations having improved stability | |
ATE415943T1 (de) | Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff | |
TW200517142A (en) | Amorphous, spray-dried powders having a reduced moisture content and a high-long term stability | |
WO2003035051A3 (en) | The use of proton sequestering agents in drug formulations | |
WO2007090822A3 (de) | Pharmazeutische formulierung für aerosole mit zwei oder mehr wirkstoffen und mindestens einer oberflächenaktiven substanz | |
WO2005044226A3 (en) | Lipid formulations for spontaneous drug encapsulation | |
WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
IL179012A (en) | A drug containing cetirizine for the treatment of nasal inflammation, a process for its preparation and use | |
AU2002231654A1 (en) | Pharmaceutical paste comprising an acid-labile active ingredient | |
MY137752A (en) | Medicament for treating aseptic inflammations containing anemonin as effective component | |
AU2003233921A1 (en) | Atomizable liposomes and their use for the pulmonary administration of active substances | |
EP0682942A4 (de) | Neue, perkutan absorbierbare zubereitung. | |
WO2005037256A3 (de) | Flüssige zubereitung enthaltend tobramycin | |
MXPA04005783A (es) | Formulacion farmaceutica que comprende ciclosporina y uso de la misma. | |
WO2007044348A3 (en) | Anti-infective hygiene products based on cellulose acetate phthalate | |
WO2005044186A3 (en) | Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same | |
WO2002000208A3 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 11106999 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004790427 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/004132 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2542666 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004281531 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1075/KOLNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 546824 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006114451 Country of ref document: RU Ref document number: A20060450 Country of ref document: BY |
|
ENP | Entry into the national phase |
Ref document number: 2004281531 Country of ref document: AU Date of ref document: 20041014 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004281531 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004790427 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0415470 Country of ref document: BR |